Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spyropoulos

Showing results (511-520 of 640) with videos related to

Pageof 64
Sort By:
Journal of Thrombosis and Thrombolysis|March 2, 2011
Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocolAlexander Thomas Cohen, Theodore Erich Spiro, Harry Roger Büller, et al.
Journal of the American Heart Association|May 10, 2022
Incidence and Prognostic Implications of Readmissions Caused by Thrombotic Events After a Heart Failure HospitalizationPulkit Chaudhury, Paulino Alvarez, Madonna Michael, et al.
Thrombosis and Haemostasis|November 8, 2005
Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patientsAlexander T Cohen, Raza Alikhan, Juan I Arcelus, et al.
Thrombosis and Haemostasis|September 4, 2014
Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacementJ G Mathew, A C Spyropoulos, A Yusuf, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 13, 2018
Effectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous ThrombosisChristine G Kohn, Gary H Lyman, Jan Beyer-Westendorf, et al.
Annals of the Rheumatic Diseases|January 22, 2026
CD40-CD40L inhibition attenuates platelet-neutrophil interaction and neutrophil extracellular trap release in primary antiphospholipid syndromeStavros Naoum, Charilaos Spyropoulos, Andriani Angelopoulou, et al.
The New England Journal of Medicine|February 8, 2013
Rivaroxaban for thromboprophylaxis in acutely ill medical patientsAlexander T Cohen, Theodore E Spiro, Harry R Büller, et al.
Blood|November 12, 2010
Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO modelNeil A Goldenberg, Alex C Spyropoulos, Jonathan L Halperin, et al.
Placenta|January 4, 2015
PET/CT imaging reveals unrivaled placental avidity for glucose compared to other tissuesA B Sawatzke, A W Norris, F Spyropoulos, et al.
The American Surgeon|April 5, 2012
Laparoscopic repair of giant paraesophageal hernia with synthetic mesh: 45 consecutive casesGeorge Stavropoulos, Ioannis I Flessas, Theodoros Mariolis-Sapsakos, et al.
Pageof 64

Showing results (511-520 of 640) with videos related to

Sort By:
Pageof 64
Journal of Thrombosis and Thrombolysis|March 2, 2011
Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocolAlexander Thomas Cohen, Theodore Erich Spiro, Harry Roger Büller, et al.
Journal of the American Heart Association|May 10, 2022
Incidence and Prognostic Implications of Readmissions Caused by Thrombotic Events After a Heart Failure HospitalizationPulkit Chaudhury, Paulino Alvarez, Madonna Michael, et al.
Thrombosis and Haemostasis|November 8, 2005
Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patientsAlexander T Cohen, Raza Alikhan, Juan I Arcelus, et al.
Thrombosis and Haemostasis|September 4, 2014
Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacementJ G Mathew, A C Spyropoulos, A Yusuf, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 13, 2018
Effectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous ThrombosisChristine G Kohn, Gary H Lyman, Jan Beyer-Westendorf, et al.
Annals of the Rheumatic Diseases|January 22, 2026
CD40-CD40L inhibition attenuates platelet-neutrophil interaction and neutrophil extracellular trap release in primary antiphospholipid syndromeStavros Naoum, Charilaos Spyropoulos, Andriani Angelopoulou, et al.
The New England Journal of Medicine|February 8, 2013
Rivaroxaban for thromboprophylaxis in acutely ill medical patientsAlexander T Cohen, Theodore E Spiro, Harry R Büller, et al.
Blood|November 12, 2010
Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO modelNeil A Goldenberg, Alex C Spyropoulos, Jonathan L Halperin, et al.
Placenta|January 4, 2015
PET/CT imaging reveals unrivaled placental avidity for glucose compared to other tissuesA B Sawatzke, A W Norris, F Spyropoulos, et al.
The American Surgeon|April 5, 2012
Laparoscopic repair of giant paraesophageal hernia with synthetic mesh: 45 consecutive casesGeorge Stavropoulos, Ioannis I Flessas, Theodoros Mariolis-Sapsakos, et al.
Pageof 64